Two Sigma Advisers, LP

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
2,360
Total Value
44417954494
Accession Number
0000899140-25-000679
Form Type
13F-HR
Manager Name
Two Sigma Advisers, LP
Data Enrichment
97% identified
2,287 identified73 unidentified

Holdings

2,360 positions
Manager:
Search and click to pin securities to the top
Page 94 of 118
Frontline plc
Shares:
27920(-97.1%)
Value:
$414.6M(-97.0%)
Marcus & Millichap, Inc.
Shares:
12000(-5.5%)
Value:
$413.4M(-14.9%)
CONDUENT Inc
Shares:
152900(-33.5%)
Value:
$412.8M(-55.5%)
DiamondRock Hospitality Co
Shares:
53400(+11.0%)
Value:
$412.2M(-5.1%)
TRUSTMARK CORP
Shares:
11947
Value:
$412.1M
Riley Exploration Permian, Inc.
Shares:
14000(-33.6%)
Value:
$408.4M(-39.4%)
STAR GROUP, L.P.
Shares:
30900(-0.3%)
Value:
$407.3M(+13.8%)
REPUBLIC BANCORP INC /KY/
Shares:
6341(-8.6%)
Value:
$404.7M(-16.6%)
Magnera Corp
Shares:
22260(+2.8%)
Value:
$404.2M(+2.7%)
Apollo Commercial Real Estate Finance, Inc.
Shares:
42200
Value:
$403.9M
JAKKS PACIFIC INC
Shares:
16360
Value:
$403.6M
ZEBRA TECHNOLOGIES CORP
Shares:
1423
Value:
$402.1M
Commercial Vehicle Group, Inc.
Shares:
348200(+159.8%)
Value:
$400.4M(+20.5%)
Angel Oak Mortgage REIT, Inc.
Shares:
42000(+57.3%)
Value:
$400.3M(+61.5%)
MOOG INC.
Shares:
2300
Value:
$398.7M
CENTERPOINT ENERGY INC
Shares:
11000
Value:
$398.5M
BROOKFIELD Corp /ON/
Shares:
7600
Value:
$398.3M
NEUROCRINE BIOSCIENCES INC
Shares:
3600
Value:
$398.2M
RAPT Therapeutics, Inc.
Shares:
325900(-35.3%)
Value:
$397.6M(-50.0%)
NV5 Global, Inc.
Shares:
20500(-69.7%)
Value:
$395.0M(-69.0%)